Page-1
VICC BRE 12101 A Phase Ib Trial of BYL719 (an á-Specific PI3K... VICC BRE 12116 An Open-Label, Phase I Study of ARN-810 in... VICC BRE 1280 A Phase III Randomized, Double Blind Placebo... VICC PHI 1248 An Open-Label, Phase I, Dose-Escalation Study... VICC PHI 1248 An Open-Label, Phase I, Dose-Escalation Study... VICC BRE 1202 A phase Ib, open-label, dose-escalation study of... VICC BRE 1172 A Phase II Double-Blind Placebo-Controlled... VICC PHI 1142 A Phase Ib dose-escalation study of the safety... VICC PHI 1142 A Phase Ib dose-escalation study of the safety... VICC PHI 1142 A Phase Ib dose-escalation study of the safety... VICC PHI 1065 A Phase IA, Multicenter, Open-Label Dose... VICC BRE 1114 Phase II Trial of AKT Inhibitor MK2206 in... VICC RAD 1060 A Phase I Trial of Sorafenib and Stereotactic... Click here to print
this page (PDF) Breast Cancer Flowcharts